David Hurewitz

2.1k total citations
25 papers, 834 citations indexed

About

David Hurewitz is a scholar working on Genetics, Rheumatology and Hematology. According to data from OpenAlex, David Hurewitz has authored 25 papers receiving a total of 834 indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Genetics, 8 papers in Rheumatology and 8 papers in Hematology. Recurrent topics in David Hurewitz's work include Coagulation, Bradykinin, Polyphosphates, and Angioedema (24 papers), Hemophilia Treatment and Research (8 papers) and Urticaria and Related Conditions (8 papers). David Hurewitz is often cited by papers focused on Coagulation, Bradykinin, Polyphosphates, and Angioedema (24 papers), Hemophilia Treatment and Research (8 papers) and Urticaria and Related Conditions (8 papers). David Hurewitz collaborates with scholars based in United States, Germany and Israel. David Hurewitz's co-authors include Timothy Craig, Robyn J. Levy, Richard L. Wasserman, Againdra K. Bewtra, Jonathan A. Bernstein, Krystyna Obtułowicz, Avner Reshef, Peter Kießling, Dumitru Moldovan and Bruce Ritchie and has published in prestigious journals such as SHILAP Revista de lepidopterología, Annals of Internal Medicine and CHEST Journal.

In The Last Decade

David Hurewitz

25 papers receiving 797 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
David Hurewitz United States 14 771 359 262 256 249 25 834
Henrik Balle Boysen United States 10 664 0.9× 273 0.8× 228 0.9× 196 0.8× 170 0.7× 12 717
Dumitru Moldovan Romania 17 943 1.2× 375 1.0× 277 1.1× 275 1.1× 339 1.4× 36 1.0k
L. Bouillet France 9 611 0.8× 285 0.8× 241 0.9× 181 0.7× 168 0.7× 17 652
Inmaculada Martinez‐Saguer Germany 20 1.1k 1.4× 506 1.4× 418 1.6× 373 1.5× 312 1.3× 55 1.2k
Anthony J. Castaldo United States 12 1.3k 1.7× 538 1.5× 480 1.8× 392 1.5× 339 1.4× 19 1.4k
Thomas Machnig United States 15 582 0.8× 225 0.6× 182 0.7× 195 0.8× 183 0.7× 37 626
Beáta Visy Hungary 10 563 0.7× 235 0.7× 209 0.8× 175 0.7× 214 0.9× 22 604
M. Baş Germany 5 448 0.6× 226 0.6× 175 0.7× 99 0.4× 129 0.5× 7 476
E. Rusicke Germany 9 413 0.5× 164 0.5× 149 0.6× 147 0.6× 150 0.6× 23 449
G. Martignoni Italy 8 173 0.2× 43 0.1× 108 0.4× 73 0.3× 82 0.3× 24 429

Countries citing papers authored by David Hurewitz

Since Specialization
Citations

This map shows the geographic impact of David Hurewitz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David Hurewitz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David Hurewitz more than expected).

Fields of papers citing papers by David Hurewitz

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David Hurewitz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David Hurewitz. The network helps show where David Hurewitz may publish in the future.

Co-authorship network of co-authors of David Hurewitz

This figure shows the co-authorship network connecting the top 25 collaborators of David Hurewitz. A scholar is included among the top collaborators of David Hurewitz based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David Hurewitz. David Hurewitz is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Malbrán, Alejandro, Marc A. Riedl, Bruce Ritchie, et al.. (2014). Repeat treatment of acute hereditary angioedema attacks with open-label icatibant in the FAST-1 trial. Clinical & Experimental Immunology. 177(2). 544–553. 32 indexed citations
2.
Lumry, William R., Michael Manning, David Hurewitz, et al.. (2013). Nanofiltered C1-Esterase Inhibitor for the Acute Management and Prevention of Hereditary Angioedema Attacks due to C1-Inhibitor Deficiency in Children. The Journal of Pediatrics. 162(5). 1017–1022.e2. 46 indexed citations
3.
Schneider, Lynda C., David Hurewitz, Richard L. Wasserman, et al.. (2012). C1‐INH concentrate for treatment of acute hereditary angioedema: a pediatric cohort from the I.M.P.A.C.T. studies. Pediatric Allergy and Immunology. 24(1). 54–60. 29 indexed citations
4.
Craig, Timothy, Againdra K. Bewtra, David Hurewitz, et al.. (2012). Treatment response after repeated administration of C1 esterase inhibitor for successive acute hereditary angioedema attacks. Allergy and Asthma Proceedings. 33(4). 354–361. 13 indexed citations
5.
Riedl, Marc A., David Hurewitz, Robyn J. Levy, et al.. (2011). Nanofiltered C1 esterase inhibitor (human) for the treatment of acute attacks of hereditary angioedema: an open-label trial. Annals of Allergy Asthma & Immunology. 108(1). 49–53. 24 indexed citations
6.
Craig, Timothy, Againdra K. Bewtra, Sami L. Bahna, et al.. (2011). C1 esterase inhibitor concentrate in 1085 Hereditary Angioedema attacks - final results of the I.M.P.A.C.T.2 study. Allergy. 66(12). 1604–1611. 104 indexed citations
7.
Gower, Richard, Paula J. Busse, Emel Aygören‐Pürsün, et al.. (2011). Hereditary Angioedema Caused By C1-Esterase Inhibitor Deficiency: A Literature-Based Analysis and Clinical Commentary on Prophylaxis Treatment Strategies. World Allergy Organization Journal. 4(2). S9–S21. 35 indexed citations
8.
Christensen, Edward E., David Hurewitz, & Steven M. Sullivan. (2011). Successful Hereditary Angioedema Prophylaxis With C1 Inhibitor in Orthognathic Surgery. Journal of Oral and Maxillofacial Surgery. 70(6). 1456–1458. 6 indexed citations
9.
Gower, Richard, Paula J. Busse, Emel Aygören‐Pürsün, et al.. (2011). Hereditary Angioedema Caused By C1-Esterase Inhibitor Deficiency: A Literature-Based Analysis and Clinical Commentary on Prophylaxis Treatment Strategies. SHILAP Revista de lepidopterología. 4. S9–S21. 27 indexed citations
10.
Gower, Richard, Paula J. Busse, Emel Aygören‐Pürsün, et al.. (2011). Hereditary Angioedema Caused By C1-Esterase Inhibitor Deficiency: A Literature-Based Analysis and Clinical Commentary on Prophylaxis Treatment Strategies. World Allergy Organization Journal. 4(Suppl 2). S9–S9. 4 indexed citations
11.
Bernstein, Jonathan A., Bruce Ritchie, Robyn J. Levy, et al.. (2011). Hereditary angioedema: Validation of the end point time to onset of relief by correlation with symptom intensity. Allergy and Asthma Proceedings. 32(1). 36–42. 11 indexed citations
12.
Wasserman, Richard L., Robyn J. Levy, Againdra K. Bewtra, et al.. (2010). Prospective study of C1 esterase inhibitor in the treatment of successive acute abdominal and facial hereditary angioedema attacks. Annals of Allergy Asthma & Immunology. 106(1). 62–68. 13 indexed citations
13.
Bernstein, Jonathan A., Bruce Ritchie, Robyn J. Levy, et al.. (2010). Population pharmacokinetics of plasma-derived C1 esterase inhibitor concentrate used to treat acute hereditary angioedema attacks. Annals of Allergy Asthma & Immunology. 105(2). 149–154. 24 indexed citations
14.
Bewtra, Againdra K., Jonathan A. Bernstein, Bruce Ritchie, et al.. (2010). C1 Esterase Inhibitor: Retrospective Validation of a Commonly Used Endpoint in Hereditary Angioedema Studies, Time to Onset of Relief, in a Global, Multicenter, Randomized, Placebo-Controlled Study (I.M.P.A.C.T.1). Journal of Allergy and Clinical Immunology. 125(2). AB165–AB165. 1 indexed citations
15.
Craig, Timothy, Marc A. Riedl, Mark S. Dykewicz, et al.. (2009). When is prophylaxis for hereditary angioedema necessary?. Annals of Allergy Asthma & Immunology. 102(5). 366–372. 60 indexed citations
16.
Baker, James, Albert L. Sheffer, Jim Christensen, et al.. (2009). Cinryze™ Replacement Therapy in Hereditary Angioedema and Pregnancy. Journal of Allergy and Clinical Immunology. 123(2). S106–S106. 8 indexed citations
17.
Zuraw, Bruce L., Paula J. Busse, Martha V. White, et al.. (2008). Efficacy and Safety of Long-Term Prophylaxis with C1 Inhibitor (C1INH) Concentrate in Patients with Hereditary Angioedema (HAE). Journal of Allergy and Clinical Immunology. 121(2). S272–S272. 4 indexed citations
18.
19.
Mathison, David A., et al.. (1977). Hypocomplementemia in Chronic Idiopathic Urticaria. Annals of Internal Medicine. 86(5). 534–538. 79 indexed citations
20.
Farr, Richard S., et al.. (1973). Asthma without Wheezing. CHEST Journal. 63(4). 64S–68S. 21 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Henrik Balle Boysen Breakdown of academic impact, for papers by Dumitru Moldovan Breakdown of academic impact, for papers by L. Bouillet Breakdown of academic impact, for papers by Inmaculada Martinez‐Saguer Breakdown of academic impact, for papers by Anthony J. Castaldo Breakdown of academic impact, for papers by Thomas Machnig Breakdown of academic impact, for papers by Beáta Visy Breakdown of academic impact, for papers by M. Baş Breakdown of academic impact, for papers by E. Rusicke Breakdown of academic impact, for papers by G. Martignoni
Rankless by CCL
2026